Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
Abstract An updated meta-analysis incorporating nine randomized trials (n = 816) investigating low-to-moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome (ARDS) show moderate-to-high quality evidence that glucocorticoid therapy is safe and reduces (i) time to endo...
Main Authors: | Gianfranco Umberto Meduri, Reed A. C. Siemieniuk, Rachel A. Ness, Samuel J. Seyler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40560-018-0321-9 |
Similar Items
-
Comparison of treatment duration in different malocclusions
by: Parag S Majithia, et al.
Published: (2013-01-01) -
Effects of Methylprednisolone on Ventilator-Free Days in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome and COVID-19: A Retrospective Study
by: Mohamed Badr, et al.
Published: (2021-02-01) -
Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013-03-01) -
Plasma biomarker analysis in pediatric ARDS: generating future framework from a pilot randomized control trial of methylprednisoloneA framework for identifying plasma biomarkers related to clinical outcomes in pediatric ARDS
by: Dai eKimura, et al.
Published: (2016-03-01) -
Correlation of red cell distribution width value with the duration of mechanical ventilator usage in patients treated in pediatric intensive care unit
by: I Nyoman Budi Hartawan, et al.
Published: (2020-01-01)